Geron Corporation (Nasdaq: GERN) today announced that David L. Greenwood, President and Chief Executive Officer, will present a company update at 4:00 p.m. EDT on Wednesday, June 8, 2011, at the Jefferies 2011 Global Healthcare Conference in New York City.

The webcast for the live audio and slide presentation will be available at http://www.wsw.com/webcast/jeff60/gern/ . The presentation will be archived for replay and available at the same address one hour after conclusion of the live event for a period of 30 days.

About Geron

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases. The company is advancing anti-cancer therapies through multiple Phase 2 clinical trials in different cancers by targeting the enzyme telomerase and with a compound designed to penetrate the blood-brain barrier. The company is developing cell therapies from differentiated human embryonic stem cells for a range of indications, with the first product in a Phase 1 clinical trial for spinal cord injury. For more information, visit www.geron.com.